PRIME

Globee® Awards Announces Winners in the 9th Annual 2021 CEO World Awards®

Wednesday, September 15, 2021 - 4:30pm

SAN FRANCISCO, Sept. 15, 2021 /PRNewswire-PRWeb/ -- The Globee Awards organizer of the world's premier business awards programs and business ranking lists has announced the Grand, Gold, Silver, and Bronze winners in the 9th Annual 2021 CEO World Awards.

Key Points: 
  • SAN FRANCISCO, Sept. 15, 2021 /PRNewswire-PRWeb/ -- The Globee Awards organizer of the world's premier business awards programs and business ranking lists has announced the Grand, Gold, Silver, and Bronze winners in the 9th Annual 2021 CEO World Awards.
  • Winners of Grand GLOBEE CEO World Awards include Best Version Media, NewAge, Inc., P. F. Chang's, Piano, and Tek Leaders Inc.
  • The Annual CEO World Awards is part of the Globee Awards recognition program.
  • For a complete list of the 2021 CEO World Award winners announced, visit https://globeeawards.com/ceo-world-awards/winners/
    Stay posted and read success stories of organizations by subscribing to the Globee Newsletter: https://globeeawards.com/subscribe/
    Globee Awards are conferred in eleven programs and competition: the American Best in Business Awards, Business Excellence Awards (Best Employers), CEO World Awards, Communications Excellence Awards, Cyber Security Global Excellence Awards, Disruptor Company Awards, Golden Bridge Awards, International Best in Business Awards, IT World Awards, Sales, Marketing, & Service Excellence Awards, and Women World Awards.

KBS Signs Four-Floor Lease Extension With 72-Year-Old Law Firm at 510,268 Square-Foot Class A Office Property in Atlanta, Georgia

Tuesday, September 14, 2021 - 4:00pm

The property, the first LEED Silver Core & Shell-certified building constructed in the world, is part of Singapore-based PRIME US REIT's portfolio.

Key Points: 
  • The property, the first LEED Silver Core & Shell-certified building constructed in the world, is part of Singapore-based PRIME US REIT's portfolio.
  • KBS, one of the largest investors in premier commercial real estate, serves as the U.S.-based asset manager for the portfolio.
  • The Atlanta market is experiencing a record high construction pipeline and healthy leasing performance , especially in the midtown submarket.
  • Glenn Kolker and Sonia Winfield of Cushman & Wakefield represented KBS as asset manager for PRIME US REIT in the lease transaction.

MeiraGTx Announces Data at EURETINA 2021 Virtual Meeting Demonstrating Reversal of Disease Progression Following Treatment with AAV5-RPGR in X-Linked Retinitis Pigmentosa

Thursday, September 9, 2021 - 1:30pm

These data were presented today in an oral session at the EURETINA 2021 Virtual Meeting.

Key Points: 
  • These data were presented today in an oral session at the EURETINA 2021 Virtual Meeting.
  • MeiraGTx and Janssen are preparing to initiate the pivotal Phase 3 Lumeos clinical trial of AAV5-RPGR for the treatment of patients with XLRP.
  • AAV5-RPGR is an investigational gene therapy for the treatment of patients with XLRP caused by disease-causing variants in the eye-specific form of the RPGR gene (RPGR ORF15).
  • MGT011 has enrolled over 135 participants with retinal function data available and in some patients with almost 5.5 years of follow up data.

SBA Awards $5.2 Million in PRIME Grants to Help Emerging Micro-entrepreneurs Gain Access to Capital

Friday, September 3, 2021 - 3:29pm

This year, SBA focused our PRIME grant selection process on our nonprofit partners who can best bring federal resources to life, especially in the regions and communities where they are needed most.

Key Points: 
  • This year, SBA focused our PRIME grant selection process on our nonprofit partners who can best bring federal resources to life, especially in the regions and communities where they are needed most.
  • I look forward to partnering with these organizations as they help us connect Americas entrepreneurs with the capital they need to start and grow their enterprises."
  • The PRIME grants range from $75,000 to $250,000, and typically require at least 50 percent in matching funds or in-kind contributions.
  • For more information on the SBAs PRIME grants and a list of this years grantees, visit https://www.sba.gov/document/support-prime-grantees.

Mustang Bio Reports Second Quarter 2021 Financial Results and Recent Corporate Highlights

Monday, August 16, 2021 - 9:01pm

WORCESTER, Mass., Aug. 16, 2021 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (Mustang) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating todays medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors and rare genetic diseases, today announced financial results and recent corporate highlights for the second quarter ended June 30, 2021.

Key Points: 
  • WORCESTER, Mass., Aug. 16, 2021 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (Mustang) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating todays medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors and rare genetic diseases, today announced financial results and recent corporate highlights for the second quarter ended June 30, 2021.
  • Research and development expenses including license acquisitions were $11.9 million for the second quarter of 2021, compared to $11.1 million for the second quarter of 2020.
  • Non-cash, stock-based expenses included in research and development were $0.3 million for the second quarter of 2021, compared to $0.4 million for the second quarter of 2020.
  • General and administrative expenses were $2.5 million for the second quarter of 2021, compared to $3.0 million for the second quarter of 2020.

Scholar Rock Reports Second Quarter 2021 Financial Results and Highlights Business Progress

Tuesday, August 10, 2021 - 9:15pm

Scholar Rock (NASDAQ: SRRK), a clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, today reported financial results for the second quarter ended June 30, 2021, and highlighted recent progress and upcoming milestones for its pipeline programs.

Key Points: 
  • Scholar Rock (NASDAQ: SRRK), a clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, today reported financial results for the second quarter ended June 30, 2021, and highlighted recent progress and upcoming milestones for its pipeline programs.
  • Research and development expense was $25.6 million for the quarter ended June 30, 2021 compared to $17.0 million for the quarter ended June 30, 2020.
  • General and administrative expense was $9.3 million for the quarter ended June 30, 2021 compared to $6.4 million for the quarter ended June 30, 2020.
  • Scholar Rock is a registered trademark of Scholar Rock, Inc.